Cargando…
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
In light of an increasing number of vaccinated and convalescent individuals, there is a major need for the development of robust methods for the quantification of neutralizing antibodies; although, a defined correlate of protection is still missing. Sera from hospitalized COVID-19 patients suffering...
Autores principales: | Herrlein, Marie-Luise, Hein, Sascha, Zahn, Tobias, Mhedhbi, Ines, Raupach, Jan, Husria, Younes, Benz, Nuka Ivalu, Eisert, Jonathan, Bender, Daniela, Haberger, Vanessa, Hastert, Florian D., Henss, Lisa, Schnierle, Barbara S., Stingl, Julia C., Dreher, Michael, Hildt, Eberhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879086/ https://www.ncbi.nlm.nih.gov/pubmed/35216003 http://dx.doi.org/10.3390/v14020410 |
Ejemplares similares
Cargando…
ANTISERA, TOXOIDS, VACCINES AND TUBERCULINS IN PROPHYLAXIS AND TREATMENT
Publicado: (1961)
Publicado: (1961)
Ejemplares similares
-
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021) -
The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
por: Hastert, Florian D., et al.
Publicado: (2022) -
Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination
por: Hein, Sascha, et al.
Publicado: (2022) -
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19
por: Zahn, Tobias, et al.
Publicado: (2021) -
The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response
por: Hein, Sascha, et al.
Publicado: (2023)